As shown in Figure 3(c), upregulated Beclin-1 expression in stage III CRC patients was a protective factor for OS (HR = 0.04, 95% CI (0.02–0.08), P < 0.001). This evidence concerns the gene BECN1 and colorectal carcinoma.